Phase 3 Clinical Data on Vosorotide for Achondroplasia Presented at ASBMR Annual Meeting
Last week, biotechnology company BioMarin announced that Dr. Lynda Polgreen, MD, MS would present at the American Society for Bone and Mineral Research (ASBMR) Annual 2020 Meeting. Her presentation centered…